Shutdown Deal Avoids Further US FDA Service Cuts, But Damage May Linger
Executive Summary
Employees are no doubt are excited to resume work and may have a dozen or more major NDAs pending, but agency morale may not recover quickly.
You may also be interested in...
No Shutdown But Funding Lower Than House Bill In US FDA Budget Forecast
Former Senate Appropriations Committee staffer expects FDA's FY 2020 budget will not be finalized until early next year and that it will be close to the sum in the appropriations bill passed by the Senate.
US FDA's Budget Forecast: No Shutdown, But Funding Down From House Mark
Former Senate Appropriations Committee staffer expects FDA's FY 2020 budget will not be finalized until early next year and that it will be close to the sum in the appropriations bill passed by the Senate.
Cures Act Hiring Authority Expansion Could Help Recruitment Woes, US FDA's Sharpless Says
Acting commissioner says greater flexibility in hiring has 'a real potential to solve some of our problems,' although only about 40-50 people have been added to date; recruitment and retention were very much on the minds of the FDA’s leadership at the recent BIO annual meeting, where center directors spoke of the long-term damage caused by the five-week partial government shutdown.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: